Top Stories
Addition of Atezolizumab to FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer

The addition of atezolizumab to FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, irinotecan) and bevacizumab improved progression-free survival in the first-line treatment of patients with metasta

The ASCO Post
4d ago
Length of Stay and Cost of Care Associated With Admissions for Atrial Fibrillation Among Patients With Cancer

The aim of this study is to assess the burden of AF-related hospitalizations inclusive of inflation-adjusted cost-of-care and length-of-stay (LOS) among cancer patients and the impact of direct cur

BMC Cardiovascular Disorders
4d ago
Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

Researchers characterized possible features of multiple myeloma (MM) cells that may be related to bortezomib (BTZ) resistance in patients with MM, in a new study published in the journal Cell D

Hematology Advisor
4d ago
No Results Found
No Results Found